Cite
HARVARD Citation
Carbery, I. et al. (n.d.). P731 Effect on direct and indirect costs of switching Inflammatory Bowel Disease patients from intravenous to subcutaneous infliximab (CT-P13). Journal of Crohn's and colitis. p. i861. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carbery, I. et al. (n.d.). P731 Effect on direct and indirect costs of switching Inflammatory Bowel Disease patients from intravenous to subcutaneous infliximab (CT-P13). Journal of Crohn's and colitis. p. i861. [Online].